Evidence map›Paper›PMID 27214750›Full record

ArticleClinical and translational science2016

Implementing Pharmacogenomics at Your Institution: Establishment and Overcoming Implementation Challenges.

M J Arwood, S Chumnumwat, L H Cavallari, E A Nutescu, J D Duarte

Abstract read
In one paragraph

Article in Clinical and translational science, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Pharmacogenomics · 2023
    Article
  9. How to Implement a Pharmacogenetics Service at your Institution.Journal of the American College of Clinical Pharmacy : JACCP · 2022
    Article
  10. CYP2D6 pharmacogenetics and phenoconversion in personalized medicine.Expert opinion on drug metabolism & toxicology · 2022
    Review
  11. Review
  12. Advancing Pharmacogenomics from Single-Gene to Preemptive Testing.Annual review of genomics and human genetics · 2022
    Review
  13. Review
  14. Article
  15. Pharmacogenetics: A Precision Medicine Approach to Combatting the Opioid Epidemic.Journal of the American College of Clinical Pharmacy : JACCP · 2022
    Article
  16. Pharmacogenetic Testing Knowledge and Attitudes among Pediatric Psychiatrists and Pediatricians in Alberta, Canada.Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent · 2022
    Article
  17. A Comprehensive Review ofPharmaceuticals (Basel, Switzerland) · 2021
    Review
  18. Approaches to assessing the provider experience with clinical pharmacogenomic information: a scoping review.Genetics in medicine : official journal of the American College of Medical Genetics · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

M J ArwoodDepartment of Pharmacotherapy and Translational Research, University of Florida College of Pharmacy, Gainesville, Florida, USA.
S ChumnumwatDepartment of Pharmacy, Faculty of Pharmacy, Mahidol University, Rajathevi, Bangkok, Thailand.
L H CavallariDepartment of Pharmacotherapy and Translational Research, University of Florida College of Pharmacy, Gainesville, Florida, USA.
E A NutescuPersonalized Medicine Program, University of Illinois College of Pharmacy, Chicago, Illinois, USA.
J D DuarteDepartment of Pharmacotherapy and Translational Research, University of Florida College of Pharmacy, Gainesville, Florida, USA.

Funding

Sparking Advancements in Genomic MedicineU01HG007269 · NHGRI · UNIVERSITY OF FLORIDA · PI CAVALLARI, LARISA HUMMA, JOHNSON, JULIE A. · 2013 to 2024
$17.0M
Improving treatment personalization for pulmonary hypertension associated with diastolic heart failureK23GM112014 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DUARTE, JULIO DAVID · 2015 to 2018
$711k
Patient-Centered Anticoagulation Self-Monitoring in Minority Patients.K23HL112908 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI NUTESCU, EDITH · 2013 to 2016
$524k
NHGRI NIH HHS U01 HG007269NHLBI NIH HHS K23 HL112908NIGMS NIH HHS K23 GM112014NIH HHS K23 GM112014NIH HHS K23 HL112908NIH HHS U01 HG007269
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID27214750
PMCPMC5121089

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.